Babk Nejati

Babk Nejati


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2023 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
AAAkram Firouzi Amandi
Akram Firouzi Amandi
EJElham Jokar
Elham Jokar
MEMajid Eslami
Majid Eslami
MDMehdi Dadashpour
Mehdi Dadashpour
MRMehdi Rezaie
Mehdi Rezaie
BNBabk Nejati
Babk Nejati

11 September 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
VIVida Imani
Vida Imani
DADaniel Kwasi Ahorsu
Daniel Kwasi Ahorsu
NTNasrin Taghizadeh
Nasrin Taghizadeh
ZPZahra Parsapour
Zahra Parsapour
BNBabk Nejati
Babk Nejati
APAmir Pakpour
Amir Pakpour
The present study examined the mediating role of anxiety, depression, sleepiness, insomnia, and sleep quality in the association between problematic social media use and quality of life (QoL) among patients with cancer. This cross-sectional survey study recruited 288 patients with cancer to respond to measures on anxiety, depression, sleepiness, insomnia, sleep quality, problematic social media use, and QoL. Structural Equation Modeling was used for the mediation analysis. There were significant relationships between all of the variables used in the study. It was revealed that problematic social media use did not directly influence the QoL of patients with cancer except via anxiety, depression, sleepiness, and insomnia. Sleep quality did not mediate the association between problematic social media use and QoL. Healthcare workers managing cancer should pay attention to the mental health needs of their patients even as they treat their cancer so as to improve their quality of life. Future studies may examine other variables that affect the QoL of patients with cancer as well as other mediating and moderating variables.

10 July 2024 in Proceedings of Anticancer Research
Verified
Journal Article
Open access
PDF file
HBHossein Azari Bostanabad
Hossein Azari Bostanabad
SMSafa Mousavi
Safa Mousavi
MHMohammad Hossein Hosseini
Mohammad Hossein Hosseini
SSSadra Sarandili
Sadra Sarandili
AEAli Esfahani
Ali Esfahani
BNBabk Nejati
Babk Nejati
Objective: Pancytopenia is characterized by a reduction in all three types of blood cells: erythrocytes, leukocytes, and platelets. Pancytopenia is caused by a wide range of diseases, leading to diagnostic conundrums. These causes can range from drug reactions to life-threatening diseases such as aplastic anemia and leukemia. This study aims to investigate the causes of pancytopenia, specifically focusing on age and gender differences among patients. Methods: This cross-sectional study includes patients of all ages diagnosed with pancytopenia, as indicated by a CBC/H1 showing a WBC count less than 4,000/µL, platelet count less than 150,000/µL, and hemoglobin levels below 12 g/dL in women and less than 13 g/dL in men. The study only included patients with pancytopenia who underwent bone marrow examination and were not subjected to chemotherapy or radiation therapy. Results: A total of 133 patients with pancytopenia were included in the study. The average age was 47.35 ± 17.62 years old, with 66% of the participants being male and 34% being female. Acute leukemia, specifically acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL), was identified as the primary cause of pancytopenia, accounting for 31.5% of cases. Megaloblastic anemia was the second most common cause, accounting for 30% of cases, followed by aplastic anemia at 7.5%. Conclusion: Pancytopenia, a condition marked by the decrease in both erythrocytes and leukocytes as well as thrombocytes, can arise from a myriad of causes. The main findings of this study revealed that megaloblastic anemia, acute myeloid leukemia (AML), and acute lymphoid leukemia (ALL) were the most common causes. Significantly, a considerable proportion of cases of pancytopenia can be attributed to acute leukemia. Hence, expeditious and accurate diagnosis is imperative and has the potential to save lives in such cases.

19 December 2023 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
SGSaba Ghaffary
Saba Ghaffary
AJAref Javidnia
Aref Javidnia
SBSamineh Beheshtirouy
Samineh Beheshtirouy
JSJavid Sadeghi
Javid Sadeghi
AAAliakbar Movassaghpour Akbari
Aliakbar Movassaghpour Akbari
NGNasrin Gholami
Nasrin Gholami

1 July 2024 in Cureus
Verified
Journal Article
Open access
PDF file
SMSafa Mousavi
Safa Mousavi
MHMohammad Hossein Hosseini
Mohammad Hossein Hosseini
SSSadra Sarandili
Sadra Sarandili
BNBabk Nejati
Babk Nejati
Myeloperoxidase (MPO) is found in the lysosomes of monocytes and neutrophils, serving as a crucial component in the elimination of infections through the process of phagocytosis via neutrophils. Consequently, individuals with MPO deficiency exhibit a significantly heightened susceptibility to serious infections and chronic inflammatory diseases. In a clinical case, a 37-year-old Iranian woman presented with a chronic history of bacterial and fungal infections dating back to her childhood. She has no family history of similar diseases and has used antibiotics and antifungal medications. A comprehensive clinical assessment revealed that she is well-nourished and without acute distress, neurological symptoms, or cutaneous manifestations. A complete blood count (CBC) with differential white blood cell (WBC) count showed a decreased number of neutrophils despite normal WBC counts, and peripheral blood smear (PBS) revealed reduced neutrophil granulation, abnormal neutrophil morphology, decreased chromatin condensation, and cytoplasmic hypogranulation. So, the patient was diagnosed with MPO deficiency, a rare condition requiring early diagnosis and management.

11 October 2026 in International Journal of Cancer Management
Verified
Journal Article
Open access
PDF file
BNBabk Nejati
Babk Nejati
AVAmir Vahedi
Amir Vahedi
ATAmirhossein Tizhoosh
Amirhossein Tizhoosh
SPSajjad Pourasghary
Sajjad Pourasghary
Background: Deficient mismatch repair in colorectal adenocarcinoma is a clinically relevant biomarker for Lynch syndrome screening, prognostic assessment, and therapeutic stratification. However, regional data on the prevalence of dMMR and immunohistochemical patterns of protein loss remain limited in Iran. Objectives: This study aimed to determine the prevalence of dMMR and to characterize mismatch repair (MMR) protein loss patterns in a colorectal cancer cohort in Northwestern Iran. Methods: In this retrospective cross-sectional study, we analyzed consecutive colorectal cancer cases using immunohistochemistry (IHC) for MLH1, PMS2, MSH2, and MSH6. Deficient MMR was defined as the loss of nuclear expression of at least 1 MMR protein in tumor cells, with retained staining in internal control cells. We assessed the prevalence of dMMR and the distribution of MMR protein loss patterns. Results: Overall, 103 of 853 patients had dMMR, yielding a prevalence of 12.1% (95% confidence interval [CI], 10.1%–14.4%). The prevalence of dMMR was higher in 2023 than in 2024 (57/352 [16.2%] vs. 46/501 [9.2%]; P = 0.003). Diagnosis year remained associated with dMMR status after adjustment for age and sex (odds ratio [OR] for 2024 vs. 2023, 0.52; 95% CI, 0.34 - 0.79; P = 0.002), whereas age and sex were not significantly associated with dMMR status. Among dMMR tumors, combined MLH1/PMS2 loss (35.0%) and isolated PMS2 loss (30.1%) were the most frequent protein-loss patterns. Conclusions: In this Northwestern Iranian cohort, dMMR was identified in approximately 1 in 8 cases of colorectal adenocarcinoma, consistent with international prevalence estimates. The relatively high frequency of isolated PMS2 loss underscores the need for careful technical interpretation and future molecular validation to clarify its biological and diagnostic significance.